Position in PCRX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$9,389,234
+$4,953,035 QoQ
Shares Held
370,092
+88.5% QoQ
Ownership
0.928%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#23
of 251 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Derivatives in PCRX
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$7,525
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $24,089,483 across 13 Drug Manufacturers - Specialty & Generic names. PCRX ranks #1 (39.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
This page
|
370,092 | $9,389,234 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,697 | $3,628,635 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
293,670 | $2,325,866 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
10,630 | $1,791,580 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,304 | $1,534,899 | |
| 6 | ZTS |
Zoetis Inc.
|
18,525 | $1,331,206 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
34,027 | $1,231,777 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
27,400 | $991,880 |
All Filings in PCRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,389,234 | 370,092 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $4,436,199 | 196,292 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,453,740 | 172,092 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,244,355 | 48,287 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,041,848 | 43,592 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,331,156 | 174,292 | Shares | Defined | 2025-05-08 | |
| 2024-09-30 | $429,677 | 28,550 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $7,525 | 500 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $2,191,526 | 76,600 | Put | Defined | 2024-08-13 | |
| 2024-06-30 | $1,433,361 | 50,100 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,092,152 | 71,600 | Put | Defined | 2024-05-13 | |
| 2024-03-31 | $1,540,507 | 52,721 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $2,282,592 | 74,400 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $1,063,430 | 34,662 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $573,441 | 14,311 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $881,540 | 22,000 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $1,147,822 | 28,126 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $1,652,805 | 40,500 | Put | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||